Recurrent tattoo reactions in a patient treated with BRAF and MEK inhibitors

被引：8

作者：

Reinhard, R. ^{[1
,2
]}

Gebhardt, C. ^{[1
,2
]}

Schmieder, A. ^{[1
]}

Umansky, V. ^{[1
,2
]}

Utikal, J. ^{[1
,2
]}

机构：

[1] Ruprecht Karl Univ Heidelberg, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany

[2] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2017年 / 31卷 / 08期

关键词：

SUPPRESSOR-CELLS; MELANOMA;

D O I：

10.1111/jdv.14181

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E375 / E377

页数：3

共 8 条

[1] Granulomatous tattoo reaction in a patient treated with etanercept [J].

Bachmeyer, C. ;

Blum, L. ;

Petitjean, B. ;

Kemiche, F. ;

Pertuiset, E. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 (04) :550-552

[2] Granulomatous reaction to red tattoo pigment treated with allopurinol [J].

Godinho, Mariana Marteleto ;

Aguinaga, Felipe ;

Grynszpan, Rachel ;

Lima, Victor Maselli ;

Azulay, David Rubem ;

Cuzzi, Tullia ;

Ramos-e-Silva, Marcia ;

Manela-Azulay, Monica .

JOURNAL OF COSMETIC DERMATOLOGY, 2015, 14 (03) :241-245

[3] Selective BRAF inhibition decreases tumor-resident lymphocyte frequencies in a mouse model of human melanoma [J].

Hooijkaas, Anna I. ;

Gadiot, Jules ;

Morrow, Michelle ;

Stewart, Ross ;

Schumacher, Ton N. ;

Blank, Christian U. .

ONCOIMMUNOLOGY, 2012, 1 (05) :609-617

[4] Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma [J].

Long, G. V. ;

Stroyakovskiy, D. ;

Gogas, H. ;

Levchenko, E. ;

de Braud, F. ;

Larkin, J. ;

Garbe, C. ;

Jouary, T. ;

Hauschild, A. ;

Grob, J. J. ;

Sileni, V. Chiarion ;

Lebbe, C. ;

Mandala, M. ;

Millward, M. ;

Arance, A. ;

Bondarenko, I. ;

Haanen, J. B. A. G. ;

Hansson, J. ;

Utikal, J. ;

Ferraresi, V. ;

Kovalenko, N. ;

Mohr, P. ;

Probachai, V. ;

Schadendorf, D. ;

Nathan, P. ;

Robert, C. ;

Ribas, A. ;

DeMarini, D. J. ;

Irani, J. G. ;

Casey, M. ;

Ouellet, D. ;

Martin, A. -M. ;

Le, N. ;

Patel, K. ;

Flaherty, K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (20) :1877-1888

[5] Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial [J].

Long, Georgina V. ;

Stroyakovskiy, Daniil ;

Gogas, Helen ;

Levchenko, Evgeny ;

de Braud, Filippo ;

Larkin, James ;

Garbe, Claus ;

Jouary, Thomas ;

Hauschild, Axel ;

Grob, Jean-Jacques ;

Chiarion-Sileni, Vanna ;

Lebbe, Celeste ;

Mandala, Mario ;

Millward, Michael ;

Arance, Ana ;

Bondarenko, Igor ;

Haanen, John B. A. G. ;

Hansson, Johan ;

Utikal, Jochen ;

Ferraresi, Virginia ;

Kovalenko, Nadezhda ;

Mohr, Peter ;

Probachai, Volodymr ;

Schadendorf, Dirk ;

Nathan, Paul ;

Robert, Caroline ;

Ribas, Antoni ;

DeMarini, Douglas J. ;

Irani, Jhangir G. ;

Swann, Suzanne ;

Legos, Jeffrey J. ;

Jin, Fan ;

Mookerjee, Bijoyesh ;

Flaherty, Keith .

LANCET, 2015, 386 (9992) :444-451

[6] Cutaneous Granulomatous Eruption and Successful Response to Potent Topical Steroids in Patients Undergoing Targeted BRAF Inhibitor Treatment for Metastatic Melanoma [J].

Park, June J. ;

Hawryluk, Elena B. ;

Tahan, Steven R. ;

Flaherty, Keith ;

Kim, Caroline C. .

JAMA DERMATOLOGY, 2014, 150 (03) :307-311

[7] Vemurafenib reverses immunosuppression by myeloid derived suppressor cells [J].

Schilling, Bastian ;

Sucker, Antje ;

Griewank, Klaus ;

Zhao, Fang ;

Weide, Benjamin ;

Goergens, Andre ;

Giebel, Bernd ;

Schadendorf, Dirk ;

Paschen, Annette .

INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (07) :1653-1663

[8] Myeloid-derived suppressor cells in malignant melanoma [J].

Umansky, Viktor ;

Sevko, Alexandra ;

Gebhardt, Christoffer ;

Utikal, Jochen .

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 (11) :1021-1027

← 1 →